References
- Messmore H L, Jr. Natural inhibitors of the coagulation system. Sem Thromb Hemostatis 1982; 8: 267–275
- Harpel P C. Protease inhibitors-a precarious balance. N Engl J Med 1983; 309: 725–726
- Brandt J T. The role of natural coagulation inhibitors on hemostasis. Clin Lab Med 1984; 4: 245–284
- Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 516–530
- Miller N, Hultin M B, Gounder M, Zarrabi M H. Hereditory antithrombin III deficiency: Case report and review of recent therapeutic advances. Am J Hematol 1986; 21: 215–221
- Bick R L, Dukes M L, Wilson W L, Feketelf L F. Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Throm Res 1977; 10: 721
- Fujiwara K, et al. Antithrombin III concentrate in the treatment of fulminent hepatic failure. Gastroenterol Japon 1988; 23: 423–427
- Vaziri N D, Paule P, Toohey J, Hung E, Alikhani S, Darwish R, Pahl M V. Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Int Med 1984; 144: 1802–1803
- Rosenberg R D. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975; 292: 146–151
- Weenink G H, Treffers P E, Vijn P, Smorenberg-Schoorl M E, Ten Cate J W. Plasma antithrombin III levels in preeclampsia. Clin Exp Hypertension 1983; B2: 145–162
- Weenink G H, Treffers P E, Vijn P, Smorenberg-Schoorl M E, Ten Cate J W. Antithrombin III levels in preeclampsia correlate with maternal and fetal morbidity. Am J Obstet Gynecol 1984; 148: 1092–1097
- Weiner C P, Brandt J. Plasma antithrombin III activity: An aid in the diagnosis of preeclampsia/eclampsia. Am J Obstet Gynecol 1982; 142: 275–281
- Bernhardt W, Banet A. Antithrombin III concentrate in intensive care. Ric Clin Lab 1983; 13: 61–66
- Buller H R, Weenink A H, Treffers P E, Kahle L H, Otten H A, Ten Cate J W. Severe antithrombin III deficiency in a patient with pre-eclampsia. Scand J Haematol 1980; 25: 81–86
- Abildgaard U. Highly purified antithrombin III with heparin cofactor activity prepared by disc electrophoresis. Scand J Clin Invest 1968; 21: 89–91
- Abildgaard U, Lie M, Odegard O R. Antithrombin (heparin cofactor) assay with new chromogenic substrates (s-2238 and Chromozym TH). Thromb Res 1977; 11: 549–553
- Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy during delivery and in the peurperium. Gynecol Obstet Invest 1981; 12: 141–154
- Kahle L H, Schipper H G, Jenkins C SP, Ten Cate J W. Antithrombin III, evaluation of an automated antithrombin III method. Throm Res 1978; 12: 1003–1014
- Weenink G H, Treffers P E, Kahle L H, Ten Cate J W. Antithrombin III in normal pregnancy. Throm Res 1982; 26: 281–287
- Weiner C P, Brandt J. Plasma antithrombin III activity in normal pregnancy. Obstet Gynecol 1980; 56: 601–603
- Fair D S, Bahnak B R. Human hepatoma cells secrete single chain factor X, prothrombin and antithrombin III. Blood 1984; 64: 194–204
- Chan V, Chan T K. Antithrombin III on fresh and cultural human endothelial cells: A natural anticoagulant from the vascular endothelium. Throm Res 1979; 15: 209–213
- Brandt P, Jespersen J, Gregersen G. Postpartum haemolytic-uremic syndrome successfully treated with antithrombin III. Br Med J 1980; 1: 449
- Brandt P. Observations during the treatment of antithrombin III deficient women with heparin and antithrombin concentrate during pregnancy, parturition and abortion. Thromb Res 1981; 22: 15–24